Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
28 pending office actions • 16 art units • 28 examiners • 0 of 28 (0%) have an AI response strategy ready • 31 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (4%) |
| §101 + other | 4 (14%) |
| §103 only | 5 (18%) |
| §112 only | 2 (7%) |
| Double-patenting + other | 3 (11%) |
| Multi-statute (no §101) | 13 (46%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PERRY, MONICA L | 1 | 55.9% | +37.6% |
| SINGH, ESVINDER | 1 | 77.7% | +23.8% |
| BUKSA, CHRISTOPHER ALLEN | 1 | 73.4% | +19.8% |
| SHENG, CHAO | 1 | 64.1% | +27.1% |
| LUONG, PETER | 1 | 69.0% | +26.4% |
| PATEL, OM | 1 | 58.3% | +54.4% |
| OAKES, JUSTIN MONTGOMERY | 1 | — | — |
| MONTANARI, DAVID A | 1 | 64.6% | +49.1% |
| ZHANG, DUAN | 1 | 60.8% | +18.6% |
| CHESTNUT, BARRY A | 1 | 73.4% | +6.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17783359 | APPARATUS AND METHOD FOR USE OF FLUID FLOW DEVICE | LE, QUYNH DAO | 31d overdue |
| 18169293 | AMHR2-ED CANCER VACCINE FORMULATIONS | DUFFY, BRADLEY | 23d overdue |
| 18003807 | COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION | LEE, CHIHYI NMN | 6d |
| 18556564 | PROTEASE INHIBITORS AND METHODS OF USE | BARSKY, JARED | 13d |
| 19055951 | SYSTEMS AND METHODS FOR USE WITH MRI-GUIDED FOCUSED ULTRASOUND | SHENG, CHAO | 20d |
| 19262634 | HYBRID CONTROL OF A ROBOTIC SYSTEM | SINGH, ESVINDER | — |
| 19036237 | AUTOMATIC CARDIOVASCULAR MAGNETIC RESONANCE IMAGING | LUONG, PETER | — |
| 18916290 | METHODS FOR SENSING AND ANALYZING IMPACTS AND PERFORMING AN ASSESSMENT | PATEL, OM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19055951 | SYSTEMS AND METHODS FOR USE WITH MRI-GUIDED FOCUSED ULTRASOUND | SHENG, CHAO | 20d |
| 19157779 | HEAD FIXATION DEVICE | PERRY, MONICA L | — |
| 19262634 | HYBRID CONTROL OF A ROBOTIC SYSTEM | SINGH, ESVINDER | — |
| 19198193 | COMPLIANCE CORRECTION IN A ROBOTIC SYSTEM | BUKSA, CHRISTOPHER ALLEN | — |
| 19036237 | AUTOMATIC CARDIOVASCULAR MAGNETIC RESONANCE IMAGING | LUONG, PETER | — |
| 18916290 | METHODS FOR SENSING AND ANALYZING IMPACTS AND PERFORMING AN ASSESSMENT | PATEL, OM | — |
| 18675612 | GENERATING HUMAN PODOCYTE CELLS | MONTANARI, DAVID A | — |
| 18640197 | SYNTHETIC TABULAR NEURAL GENERATOR | ZHANG, DUAN | — |
| Art Unit | Apps |
|---|---|
| 3797 | 3 |
| 1625 | 2 |
| 1628 | 2 |
| 1643 | 2 |
| 3644 | 1 |
| 3796 | 1 |
| 1616 | 1 |
| 1633 | 1 |
| 1681 | 1 |
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19157779 | HEAD FIXATION DEVICE | PERRY, MONICA L | 3644 | §112 | Non-Final OA | — | Pending | Aug 19, 2025 |
| 19262634 | HYBRID CONTROL OF A ROBOTIC SYSTEM | SINGH, ESVINDER | — | §103§112Other | Non-Final OA | — | Pending | Jul 08, 2025 |
| 19198193 | COMPLIANCE CORRECTION IN A ROBOTIC SYSTEM | BUKSA, CHRISTOPHER ALLEN | — | §112 | Non-Final OA | — | Pending | May 05, 2025 |
| 19055951 | SYSTEMS AND METHODS FOR USE WITH MRI-GUIDED FOCUSED ULTRASOUND | SHENG, CHAO | 3797 | §102§103 | Final Rejection | 20d | Pending | Feb 18, 2025 |
| 19036237 | AUTOMATIC CARDIOVASCULAR MAGNETIC RESONANCE IMAGING | LUONG, PETER | 3797 | §102§103 | Non-Final OA | — | Pending | Jan 24, 2025 |
| 18916290 | METHODS FOR SENSING AND ANALYZING IMPACTS AND PERFORMING AN ASSESSMENT | PATEL, OM | — | §101§103§112 | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18891486 | SYSTEM AND METHOD FOR DIAGNOSING INFLAMMATORY BOWEL DISEASE STATE AND SEVERITY | OAKES, JUSTIN MONTGOMERY | — | §101§103 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18675612 | GENERATING HUMAN PODOCYTE CELLS | MONTANARI, DAVID A | — | §101 | Non-Final OA | — | Pending | May 28, 2024 |
| 18640197 | SYNTHETIC TABULAR NEURAL GENERATOR | ZHANG, DUAN | — | §101§102§103§112 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18701156 | MRNA VACCINE DESIGN VIA THE ALTERATION OF CODON USAGE | CHESTNUT, BARRY A | — | §103§112 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18687993 | TOPICAL DRUG TREATMENT TO PREVENT OR REDUCE CORNEAL SCARRING | OH, TAYLOR V | 1625 | §103 | Non-Final OA | — | Pending | Feb 29, 2024 |
| 18392491 | SYSTEMS AND METHODS TO IMPROVE SLEEP DISORDERED BREATHING USING CLOSED-LOOP FEEDBACK | TEJANI, ANKIT D | 3796 | §103Other | Final Rejection | — | Pending | Dec 21, 2023 |
| 18566802 | NON-CONTACT LITHOTRIPSY USING PHOTONIC NANOPARTICLES | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §102§103§112DP | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18528348 | GENERATING QUIESCENT HEPATIC STELLATE CELLS AND THEIR USE IN LIVER MODELS | LARA, CAROLINE MONSERRAT | 1633 | §102§103§112DP | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18556564 | PROTEASE INHIBITORS AND METHODS OF USE | BARSKY, JARED | 1628 | §102§112 | Final Rejection | 13d | Pending | Oct 20, 2023 |
| 18478684 | TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FMO3/TMAO PATHWAY | MAHLUM, JONATHAN DAVIS | 1625 | §103§112DP | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18275797 | MICRO RNA LIVER CANCER MARKERS AND USES THEREOF | YU, TIAN NMN | 1681 | §101§103 | Non-Final OA | — | Pending | Aug 03, 2023 |
| 18263929 | TREATMENT OF CVD AND SYSTEMIC SCEROSIS WITH BETA-1 ADRENERGIC RECEPTOR ANTIBODIES | BUNNER, BRIDGET E | 1647 | §102§112 | Non-Final OA | — | Pending | Aug 02, 2023 |
| 18226698 | SYSTEM AND METHOD FOR EXTRACTION OF JOINT-SPECIFIC MOVEMENT CAPACITY AND MOTION SIGNATURE FROM IMAGING | CELESTINE, NYROBI I | 3798 | §103 | Final Rejection | — | Pending | Jul 26, 2023 |
| 18252928 | ANTI-CD6 ANTIBODY CONJUGATES FOR TREATING T-CELL MEDIATED DISORDERS AND T-CELL LYMPHOMA/LEUKEMIA | CHATTIN, AMY MARIE | 1643 | §103§112 | Final Rejection | — | Pending | May 15, 2023 |
| 18111138 | PROTECTIVE COVER | DANIEL, ANTARIUS S | 3783 | §103§112 | Non-Final OA | — | Pending | Feb 17, 2023 |
| 18169293 | AMHR2-ED CANCER VACCINE FORMULATIONS | DUFFY, BRADLEY | 1643 | §103§112Other | Final Rejection | 23d overdue | Pending | Feb 15, 2023 |
| 18104712 | OPTIMIZING SPINE SCREW PLACEMENT | SAXENA, AKASH | 2188 | §102§103 | Non-Final OA | — | Pending | Feb 01, 2023 |
| 18003807 | COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION | LEE, CHIHYI NMN | 1628 | §102§103§112Other | Non-Final OA | 6d | Pending | Dec 29, 2022 |
| 17854597 | RADIOPAQUE TISSUE MARKER | TALTY, MARIA CHRISTINA | 3797 | §103 | Final Rejection | — | Pending | Jun 30, 2022 |
| 17783359 | APPARATUS AND METHOD FOR USE OF FLUID FLOW DEVICE | LE, QUYNH DAO | 3781 | §103§112 | Final Rejection | 31d overdue | Pending | Jun 08, 2022 |
| 17609957 | INDUCED HUMAN COLITIC ORGANOIDS | ROGERS, ERIC JASON | 1638 | §103§112 | Final Rejection | — | Pending | Nov 09, 2021 |
| 17047497 | METHODS AND COMPOSITIONS FOR TH9 CELL MEDIATED CANCER TREATMENT | ESSEX, LAURA ANN | 1675 | §103 | Non-Final OA | 13d | Pending | Oct 14, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial